Severe COVID-19

Category

RLF-100 Expanded Access Program At Houston Methodist Hospital 9-Fold Increased Probability of Survival from Critical COVID-19

Patients with critical COVID-19 and respiratory failure treated with RLF-100™ (aviptadil) have a 9-fold increased probability of survival and recovery from respiratory failure than those patients only on the standard of care, reports Relief Therapeutics Holding AG...

Flemish Institute for Biotechnology Testing Leukine on COVID-19 Patients Lungs in Hopes to Prevent Dangerous ICU Cases

Investigators at the university hospital of Ghent and the Flemish Institute for Biotechnology (VIB) have commenced a clinical trial assessing the drug Leukine to identify if it could be useful in the treatment of COVID-19 patients. The Belgium-based investigators hope...

Genentech (Roche) Collaborates with BARDA to Launch Actemra Clinical Trial for Adult Patients with Severe COVID-19 Pneumonia

Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe cases of COVID-19 in adults. In collaboration with the Biomedical Advanced Research and Development Authority (BARDA), the prominent company...

Pin It on Pinterest